Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NU-Spine, also branded as The Minimally Invasive Spine Surgery Institute, is a specialty spine-care practice focused on diagnosing and treating neck and spine conditions through minimally invasive and other surgical and non-surgical interventions. The organization operates as a clinical healthcare provider rather than a drug-development biotech or pharma company. It was founded by board-certified neurosurgeon Dr. Branko Skovrlj and has expanded across New Jersey, Pennsylvania, and Florida, with Dr. Robert J. Rothrock joining as a partner. Its services center on minimally invasive spine surgery, complex spinal care, and related outpatient treatment pathways for patients with degenerative, compressive, and deformity-related spine disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NU-Spine.